
    
      This is a single center, open label study designed to determine the effect of BLD-0409 on the
      PK of probe substrates and to evaluate the safety and tolerability of BLD-0409 administered
      alone and co-administered with a cocktail of probe substrates (i.e., Geneva cocktail less
      fexofenadine) in healthy adult volunteers.

      Geneva Cocktail (Less Fexofenadine):

        -  CYP1A2 Caffeine 50 mg

        -  CYP2C Flurbiprofen 10 mg

        -  CYP2C19 Omeprazole 10 mg

        -  CYP2D6 Dextromethorphan 10 mg

        -  CYP3A4 Midazolam 1 mg

        -  CYP2B6 Bupropion 20 mg
    
  